Medical writing for in vitro diagnostics: A different approach for the ‘hidden’ side of healthcare

Alisa M. Davis

Volume 23, Issue 3 - Non-Clinical Health Writing

Medical writing for in vitro diagnostics: A different approach for the ‘hidden’ side of healthcare

Author: Alisa M. Davis

Abstract

Medical writing for in vitro diagnostics differs from writing for pharmaceutical products in several ways. The shorter development time and lifecycle of diagnostic assays, different regulatory requirements and approval times, and upcoming changes to European Economic Area regulatory requirements are a few challenges. In addition, the type of data from in vitro diagnostic studies and relevant forums for presenting scientific diagnostic data (independently from patient data) can significantly differ from data collected in pharmaceutical clinical trials.

Keywords: In Vitro Diagnostics, Publication Planning, Diagnostic Assays

Download the full article

References

Green SF. The cost of poor blood specimen quality and errors in preanalytical processes. Clin Biochem 2013;46:1175–9.
Ec.europa.eu. European Union: Competitiveness and Innovation Programme (CIP) of the European Commission, 2007–2013 [cited 2014 April 28]. Available from: http://ec.europa.eu/enterprise/policies/single-market-goods/cemarking/about-ce-marking/index_en.htm
Proposal for a Regulation of The European Parliament and of the Council on in vitro diagnostic medical devices. COM(2012) 541 final. Brussels: European Commission [26 Sep 2012].

Volume 23, Issue 3 - Non-Clinical Health Writing

Medical writing for in vitro diagnostics: A different approach for the ‘hidden’ side of healthcare

Author: Alisa M. Davis

Abstract

References

Search

Articles

Member Login

Links

Editoral Board